Cupid Share Price Surges Nearly 60% in 1 Month; Company Raises FY27 Revenue Guidance

Cupid has emerged as one of the top-performing stocks in recent weeks, with its share price rallying nearly 60% over the past month and more than 16% in the last week.  

The sharp gain follows the company's June 2026 quarter business update, in which it projected one of its strongest quarterly performances and raised its FY27 revenue guidance. 

Cupid Share Price Share Price Performance 

As of July 8, 2026, at 11:13 AM, Cupid share price was trading at ₹224.45 each on the NSE, up 1.51% for the day. The stock opened at ₹222.33, touched an intraday high of ₹226.00, and a low of ₹222.01. 

Over the past 1 week, the stock delivered an absolute return of 16.07%, compared with 0.80% for the Nifty Total Market Index. Over the last 1 month, Cupid generated an absolute return of 59.90%, substantially outperforming the benchmark index, which gained 5.20% during the same period.  

The company's market capitalisation stood at ₹30,180.91 crore. 

Cupid Expects Q1 FY27 Revenue to Exceed ₹150 Crore 

The company stated that it is on track to report revenue exceeding ₹150 crore in the first quarter of FY27, making it one of the strongest quarterly performances in its history.  

According to the company, the strong start to the financial year reflects improved visibility across both domestic and international markets. 

Cupid Raises FY27 Revenue Guidance 

Encouraged by its June quarter performance, Cupid has increased its FY27 revenue guidance by at least 10%. The company now expects FY27 revenue to exceed ₹660 crore, compared with its earlier guidance of ₹600 crore. 

According to the company, the revised guidance reflects growing confidence in its diversified business model, expanding global opportunity pipeline, and increasing operating scale across multiple business verticals. 

Read More: Cupid Share Price in Focus; Receives SEBI Warning Letter Linked to Preferential Issue Cancellation 

Why Cupid Raised Its Revenue Outlook 

The company expects continued business growth to be supported by expanding opportunities in international B2B healthcare markets, driven by demand from institutional buyers, private sector customers, and government procurement programmes.  

It also cited the commencement of its long-term supply agreement with the Partnership for Supply Chain Management (PFSCM), Netherlands, which strengthens its position in global healthcare procurement. 

Cupid also highlighted growing opportunities in its lubricant portfolio and consumer wellness business as it expands its presence across modern trade, organised retail, and pharmacy networks.  

In addition, the company expects sustained growth in its male and female condom businesses, supported by expanded manufacturing capacity, new customer additions, and a broader market reach developed over the past 12 months. 

The company further said it continues to make progress in its In Vitro Diagnostics (IVD) business. While near-term growth expectations remain conservative, it expects the segment to become a meaningful contributor over the coming years through regulatory approvals, new product launches, and continued commercialisation efforts. 

Conclusion 

Cupid share price has delivered strong gains over the past month, significantly outperforming the broader market. The rally follows the company's June quarter business update, upward revision in FY27 revenue guidance to more than ₹660 crore and improving visibility across its domestic and international businesses. 

Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.